The company has a R &D team full of youthful spirit and innovativeness. With the expansion of our  enterprise, the category of products is increasing continuously, so we sincerely seek cooperation partners, and hope to work together to develop small molecular targeted anti-tumor drugs, intermediates and APIs pilot production technology research, clinical trial management, registration, marketing and others throughout the new drug R＆Ｄ. We can provide new drug Ｒ＆Ｄ services throughout, and also services of each specific step. Our key products are small molecular targeted anti-tumor drugs, including Crizotinib, Vandetanib, Vemurafenib,  Regorafenib and Afatinib. We have achieved a major breakthrough, and made a series of achievements in developing these drugs.

In addition, the R&D center has also been developing cardiovascular system, hypoglycemic , antivirus, antiepilepti, anti-depression drugs.

All the pharmaceutical companies and drug R&D institutions are warmly welcomed to choose anysubjects and work together with us.